These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 33071054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
    Bakr RB, Ghoneim AA, Azouz AA.
    Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM, Kassab AE, El-Malah AA, Hassan MSA.
    Eur J Med Chem; 2019 Jun 01; 171():25-37. PubMed ID: 30904755
    [Abstract] [Full Text] [Related]

  • 7. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
    Mohammed ER, Abd-El-Fatah AH, Mohamed AR, Mahrouse MA, Mohammad MA.
    Bioorg Chem; 2024 Jun 01; 147():107372. PubMed ID: 38653152
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX-2 inhibitor.
    Almarsoomi T, Osmaniye D, Sağlık BN, Levent S, Ghani U, Özkay Y, Kaplancıklı ZA.
    J Mol Recognit; 2023 Jul 01; 36(7):e3025. PubMed ID: 37191245
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
    Moraes ADTO, Miranda MDS, Jacob ÍTT, Amorim CADC, Moura RO, Silva SÂSD, Soares MBP, Almeida SMV, Souza TRCL, Oliveira JF, Silva TGD, Melo CML, Moreira DRM, Lima MDCA.
    Bioorg Med Chem; 2018 Nov 01; 26(20):5388-5396. PubMed ID: 30293795
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
    Abdelrahman MH, Youssif BGM, Abdelgawad MA, Abdelazeem AH, Ibrahim HM, Moustafa AEGA, Treamblu L, Bukhari SNA.
    Eur J Med Chem; 2017 Feb 15; 127():972-985. PubMed ID: 27837994
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH, El-Saadi MT, Safi El-Din AG, Omar HA, El-Moghazy SM.
    Bioorg Med Chem; 2017 Jan 15; 25(2):665-676. PubMed ID: 27916468
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y, Khalil NA, Ahmed EM, Hassan MSA.
    Bioorg Chem; 2021 Feb 15; 107():104610. PubMed ID: 33454504
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J, Kumar V, Sobhia ME, Jachak SM.
    Bioorg Med Chem Lett; 2014 Oct 01; 24(19):4638-4642. PubMed ID: 25219899
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA, Abou-Zeid LA, ElTahir KEH, Ayyad RR, El-Sayed MA, El-Azab AS.
    Eur J Med Chem; 2016 Oct 04; 121():410-421. PubMed ID: 27318118
    [Abstract] [Full Text] [Related]

  • 16. New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies.
    El-Kerdawy MM, Ghaly MA, Darwish SA, Abdel-Aziz HA, Elsheakh AR, Abdelrahman RS, Hassan GS.
    Bioorg Chem; 2019 Mar 04; 83():250-261. PubMed ID: 30391698
    [Abstract] [Full Text] [Related]

  • 17. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA, Elshaier YAMM, Hassanein EHM, Abdellatif KRA.
    Bioorg Chem; 2020 May 04; 98():103752. PubMed ID: 32197148
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives.
    Munir A, Khushal A, Saeed K, Sadiq A, Ullah R, Ali G, Ashraf Z, Ullah Mughal E, Saeed Jan M, Rashid U, Hussain I, Mumtaz A.
    Bioorg Chem; 2020 Nov 04; 104():104168. PubMed ID: 32947133
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives.
    Ewieda SY, Hassan RA, Ahmed EM, Abdou AM, Hassan MSA.
    Bioorg Chem; 2024 Sep 04; 150():107623. PubMed ID: 39002251
    [Abstract] [Full Text] [Related]

  • 20. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE2, TNF-α, IL-6 and histopathological study.
    Labib MB, Fayez AM, El-Nahass ES, Awadallah M, Halim PA.
    Bioorg Chem; 2020 Nov 04; 104():104308. PubMed ID: 33011534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.